Mortality in Barrett's oesophagus: results from a population based study. 2003

L A Anderson, and L J Murray, and S J Murphy, and D A Fitzpatrick, and B T Johnston, and R G P Watson, and P McCarron, and A T Gavin
Northern Ireland Cancer Registry, Department of Epidemiology and Public Health, The Queen's University Belfast, UK. l.anderson@qub.ac.uk

BACKGROUND Patients with Barrett's oesophagus have an increased risk of oesophageal adenocarcinoma but this cancer only accounts for a small proportion of deaths in these patients. Other causes of death are reportedly raised in this group. We examined cause specific mortality among individuals in a population based Barrett's oesophagus register. METHODS We constructed a register of all patients diagnosed with columnar mucosa (including specialised intestinal metaplasia) of the oesophagus within Northern Ireland between 1993 and 1999. Deaths occurring within this cohort until 31 December 2000 were identified and mortality rates were compared with the general population. RESULTS Overall mortality was not raised in Barrett's patients. During 7413 person years of follow up in 2373 patients there were 253 deaths (standardised mortality ratio (SMR) 96 (95% confidence interval (CI) 84-107)). Mortality from oesophageal cancer was raised in patients with specialised intestinal metaplasia (SMR 774 (95% CI 317-1231)) but only 4.7% of patients died from this cancer. Mortality from stroke (SMR 65 (95% CI 37-93)) was significantly lower than the general population while mortality from non-cancerous digestive system diseases was significantly higher (SMR 211 (95% CI 111-311)). Mortality rates from all other causes were similar to those of the general population. CONCLUSIONS This study demonstrates that the overall mortality rate in patients with Barrett's oesophagus is closely similar to that of the general population. Oesophageal cancer mortality was raised but is an uncommon cause of death in these patients who also appear to have a reduced risk of death from stroke.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009660 Northern Ireland The northern one-sixth of the island of Ireland - between the North Atlantic Ocean and the North Sea; northwest of France. The capital is Belfast.
D012042 Registries The systems and processes involved in the establishment, support, management, and operation of registers, e.g., disease registers. Parish Registers,Population Register,Parish Register,Population Registers,Register, Parish,Register, Population,Registers, Parish,Registers, Population,Registry
D002423 Cause of Death Factors which produce cessation of all vital bodily functions. They can be analyzed from an epidemiologic viewpoint. Causes of Death,Death Cause,Death Causes
D004938 Esophageal Neoplasms Tumors or cancer of the ESOPHAGUS. Cancer of Esophagus,Esophageal Cancer,Cancer of the Esophagus,Esophagus Cancer,Esophagus Neoplasm,Neoplasms, Esophageal,Cancer, Esophageal,Cancer, Esophagus,Cancers, Esophageal,Cancers, Esophagus,Esophageal Cancers,Esophageal Neoplasm,Esophagus Cancers,Esophagus Neoplasms,Neoplasm, Esophageal,Neoplasm, Esophagus,Neoplasms, Esophagus
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000230 Adenocarcinoma A malignant epithelial tumor with a glandular organization. Adenocarcinoma, Basal Cell,Adenocarcinoma, Granular Cell,Adenocarcinoma, Oxyphilic,Adenocarcinoma, Tubular,Adenoma, Malignant,Carcinoma, Cribriform,Carcinoma, Granular Cell,Carcinoma, Tubular,Adenocarcinomas,Adenocarcinomas, Basal Cell,Adenocarcinomas, Granular Cell,Adenocarcinomas, Oxyphilic,Adenocarcinomas, Tubular,Adenomas, Malignant,Basal Cell Adenocarcinoma,Basal Cell Adenocarcinomas,Carcinomas, Cribriform,Carcinomas, Granular Cell,Carcinomas, Tubular,Cribriform Carcinoma,Cribriform Carcinomas,Granular Cell Adenocarcinoma,Granular Cell Adenocarcinomas,Granular Cell Carcinoma,Granular Cell Carcinomas,Malignant Adenoma,Malignant Adenomas,Oxyphilic Adenocarcinoma,Oxyphilic Adenocarcinomas,Tubular Adenocarcinoma,Tubular Adenocarcinomas,Tubular Carcinoma,Tubular Carcinomas

Related Publications

L A Anderson, and L J Murray, and S J Murphy, and D A Fitzpatrick, and B T Johnston, and R G P Watson, and P McCarron, and A T Gavin
September 2011, European journal of epidemiology,
L A Anderson, and L J Murray, and S J Murphy, and D A Fitzpatrick, and B T Johnston, and R G P Watson, and P McCarron, and A T Gavin
September 2003, BMJ (Clinical research ed.),
L A Anderson, and L J Murray, and S J Murphy, and D A Fitzpatrick, and B T Johnston, and R G P Watson, and P McCarron, and A T Gavin
April 2017, Alimentary pharmacology & therapeutics,
L A Anderson, and L J Murray, and S J Murphy, and D A Fitzpatrick, and B T Johnston, and R G P Watson, and P McCarron, and A T Gavin
February 2007, Scandinavian journal of gastroenterology,
L A Anderson, and L J Murray, and S J Murphy, and D A Fitzpatrick, and B T Johnston, and R G P Watson, and P McCarron, and A T Gavin
January 2015, Gut,
L A Anderson, and L J Murray, and S J Murphy, and D A Fitzpatrick, and B T Johnston, and R G P Watson, and P McCarron, and A T Gavin
June 2000, European journal of gastroenterology & hepatology,
L A Anderson, and L J Murray, and S J Murphy, and D A Fitzpatrick, and B T Johnston, and R G P Watson, and P McCarron, and A T Gavin
May 2008, Alimentary pharmacology & therapeutics,
L A Anderson, and L J Murray, and S J Murphy, and D A Fitzpatrick, and B T Johnston, and R G P Watson, and P McCarron, and A T Gavin
October 1994, Lancet (London, England),
L A Anderson, and L J Murray, and S J Murphy, and D A Fitzpatrick, and B T Johnston, and R G P Watson, and P McCarron, and A T Gavin
June 2009, Histopathology,
L A Anderson, and L J Murray, and S J Murphy, and D A Fitzpatrick, and B T Johnston, and R G P Watson, and P McCarron, and A T Gavin
October 2005, European journal of gastroenterology & hepatology,
Copied contents to your clipboard!